Bionor Pharma ASA Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bionor Pharma are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bionor Pharma ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Bionor Pharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
Bionor |
Bionor Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in Bionor Pharma ASA on October 16, 2025 and sell it today you would earn a total of 100.00 from holding Bionor Pharma ASA or generate -100.0% return on investment over 90 days. Bionor Pharma ASA is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all stocks have less volatile historical return distribution than Bionor Pharma, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bionor Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bionor Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bionor Pharma ASA, and traders can use it to determine the average amount a Bionor Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BIONOR |
Based on monthly moving average Bionor Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bionor Pharma by adding Bionor Pharma to a well-diversified portfolio.
Things to note about Bionor Pharma ASA performance evaluation
Checking the ongoing alerts about Bionor Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bionor Pharma ASA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bionor Pharma ASA is not yet fully synchronised with the market data | |
| Bionor Pharma ASA has some characteristics of a very speculative penny stock |
- Analyzing Bionor Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bionor Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Bionor Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bionor Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bionor Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bionor Pharma's stock. These opinions can provide insight into Bionor Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Bionor Stock
If you are still planning to invest in Bionor Pharma ASA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionor Pharma's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |